Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

A weight-loss trial of the two drugs found one clear winner. In case you’re not totally clued up, Wegovy is just a different ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Shivaji Dasgupta, an autonomous Brand Consultant, writes that India’s obsession with shortcuts risks turning a breakthrough ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

Mounjaro, manufactured by US drugmaker, and Wegovy by Danish drugmaker Novo Nordisk, cause weight loss by suppressing the ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

A GRAN who shed more than five stone on Mounjaro is now fundraising to have surgery abroad – as she compares her saggy skin ...